Milestone Pharmaceuticals (MIST) Operating Income: 2021-2022
Historic Operating Income for Milestone Pharmaceuticals (MIST) over the last 1 years, with Sep 2022 value amounting to -$15.0 million.
- Milestone Pharmaceuticals' Operating Income fell 5.30% to -$15.0 million in Q3 2022 from the same period last year, while for Sep 2022 it was -$58.8 million, marking a year-over-year change of. This contributed to the annual value of -$43.1 million for FY2021, which is 15.06% up from last year.
- According to the latest figures from Q3 2022, Milestone Pharmaceuticals' Operating Income is -$15.0 million, which was up 11.16% from -$16.9 million recorded in Q4 2021.
- Over the past 5 years, Milestone Pharmaceuticals' Operating Income peaked at -$12.6 million during Q2 2021, and registered a low of -$16.9 million during Q4 2021.
- In the last 2 years, Milestone Pharmaceuticals' Operating Income had a median value of -$14.7 million in 2021 and averaged -$14.7 million.
- Data for Milestone Pharmaceuticals' Operating Income shows a maximum YoY dropped of 5.30% (in 2022) over the last 5 years.
- Quarterly analysis of 2 years shows Milestone Pharmaceuticals' Operating Income stood at -$16.9 million in 2021, then fell by 5.30% to -$15.0 million in 2022.
- Its last three reported values are -$15.0 million in Q3 2022, -$16.9 million for Q4 2021, and -$14.3 million during Q3 2021.